Latest Earnings Results: Q2 '26
Estimated EPS
-$0.29
Reported EPS
-$0.25
Surprise
+14.62%
Estimated Rev
$20.25M
Reported Rev
$21.49M
Surprise
+6.12%
• Reported GAAP EPS of -$5.00 up 34.21% YoY • Reported revenue of $21.7M up 17.83% YoY • AVITA Medical raised its full-year 2026 net revenue guidance range to $86 million to $89 million, reflecting confidence in continued commercial execution, and expects to reach cash flow breakeven in Q4 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.24 | -- | -- | N/A |
Q2 '26 | -$0.29 | -$0.25 | 14.62% | BEAT |
Q1 '26 | -$0.29 | -$0.35 | -19.86% | MISSED |
Q4 '25 | -$0.36 | -$0.38 | -4.27% | MISSED |
Q3 '25 | -$0.30 | -$0.46 | -55.56% | MISSED |